Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy. Mediterr J Hematol Infect Dis [Internet]. 2024 Apr. 30 [cited 2026 May 10];16(1):e2024049. Available from: https://www.mjhid.org/mjhid/article/view/5699